AptaBio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	16,079	25,542	25,016	1,989
Short-Term Investments	1,112	1,020	19,000	15,026
Trading Asset Securities	-	4,954	8,869	-
Cash & Short-Term Investments	17,190	31,515	52,885	17,015
Cash Growth	-45.45%	-40.41%	210.81%	-
Accounts Receivable	591.25	893.71	-	-
Other Receivables	104.64	238.05	366.31	224.46
Receivables	3,195	1,435	2,659	3,047
Inventory	612.76	224.87	-	-
Prepaid Expenses	35.28	208.43	176.31	88.23
Other Current Assets	4,318	1,552	1,754	268.93
Total Current Assets	25,351	34,935	57,474	20,419
Property, Plant & Equipment	5,861	4,962	5,129	5,848
Long-Term Investments	26,298	30,986	23,779	27,885
Goodwill	1,020	-	-	-
Other Intangible Assets	32.87	39.35	61.09	37.83
Other Long-Term Assets	1,464	3,611	3,675	1,924
Total Assets	60,027	77,434	92,519	56,114
Accounts Payable	30.42	1.87	-	-
Accrued Expenses	813.24	609.79	337.19	455.54
Short-Term Debt	4,234	7,244	-	-
Current Portion of Leases	157.86	154.6	131.08	109.73
Current Income Taxes Payable	-	-	1.48	-
Other Current Liabilities	4,480	11,529	348.2	474.75
Total Current Liabilities	9,715	19,540	817.95	1,040
Long-Term Debt	-	-	13,569	-
Long-Term Leases	30.51	122.01	233.45	256.3
Pension & Post-Retirement Benefits	3,006	3,503	3,011	2,393
Other Long-Term Liabilities	90.58	71.4	13,524	54.58
Total Liabilities	12,842	23,237	31,156	3,744
Common Stock	14,047	13,441	11,149	11,149
Additional Paid-In Capital	157,922	149,733	129,712	109,025
Retained Earnings	-126,278	-110,112	-80,713	-68,473
Comprehensive Income & Other	1,494	1,135	696.37	668.63
Total Common Equity	47,185	54,197	60,845	52,370
Shareholders' Equity	47,185	54,197	61,363	52,370
Total Liabilities & Equity	60,027	77,434	92,519	56,114
Total Debt	4,422	7,521	13,934	366.03
Net Cash (Debt)	12,768	23,994	38,951	16,649
Net Cash Growth	-46.79%	-38.40%	133.95%	-
Net Cash Per Share	474.13	1019.29	1746.78	746.98
Filing Date Shares Outstanding	27.07	26.88	22.3	22.3
Total Common Shares Outstanding	27.07	26.88	23.34	22.3
Working Capital	15,636	15,395	56,656	19,379
Book Value Per Share	1742.83	2016.16	2607.28	2348.53
Tangible Book Value	46,131	54,158	60,784	52,332
Tangible Book Value Per Share	1703.92	2014.69	2604.66	2346.83
Land	2,115	1,787	1,787	1,922
Buildings	4,123	3,215	3,046	3,388
Machinery	1,337	1,268	1,196	1,101

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.